Compare Ravinder Heights with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 2.66%
- The company has been able to generate a Return on Equity (avg) of 2.66% signifying low profitability per unit of shareholders funds
With ROE of 10.3, it has a Very Expensive valuation with a 0.8 Price to Book Value
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Ravinder Heights Ltd?
The next results date for Ravinder Heights Ltd is scheduled for 13 February 2026....
Read full news article
Ravinder Heights Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Ravinder Heights Ltd, a player in the realty sector, has seen its investment rating downgraded from Hold to Sell as of 4 February 2026, reflecting a shift in technical indicators and valuation concerns despite strong financial growth. The company’s Mojo Score now stands at 47.0, signalling caution for investors amid mixed signals across quality, valuation, financial trends, and technical parameters.
Read full news article
Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 January 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 25 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article Announcements 
Board Meeting Intimation for Board Meeting Intimation For Un-Audited Financial Results(Standalone & Consolidated) For The Quarter And Nine Months Ended 31St December 2025
09-Feb-2026 | Source : BSERavinder Heights Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Un-Audited Financial Results(Standalone & Consolidated) for the Quarter and Nine Months ended 31st December 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECompliance Certificate received under R. 74(5) of SEBI(DP) Regulations 2018 for the quarter and Nine Month ended December 31 2025
Closure of Trading Window
26-Dec-2025 | Source : BSEClosure of Trading Window
Corporate Actions 
13 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Private Limited (4.58%)
16.38%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 42,215.38% vs -7.14% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 7,767.31% vs 42.86% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -6.38% vs 74.07% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 11.96% vs -135.90% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -8.06% vs -94.85% in Mar 2024
YoY Growth in year ended Mar 2025 is -18.14% vs -134.85% in Mar 2024






